Century Therapeutics, Inc. (IPSC) Social Stream



Century Therapeutics, Inc. (IPSC): $4.18

0.09 (-2.11%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add IPSC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#202 of 365

in industry

CENTURY THERAPEUTICS INC (IPSC) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IPSC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 4 $40 $33 $36.25 $3.19 1036.36%
2022-03-17 4 $40 $32 $36 $3.19 1028.53%
2022-03-25 4 $40 $28 $34.5 $3.19 981.5%
2022-04-28 4 $40 $27 $33.25 $3.19 942.32%
2022-05-17 5 $40 $27 $33.25 $3.19 942.32%
2022-05-23 6 $34 $22 $26.666 $3.19 735.92%
2022-08-12 7 $34 $22 $26 $3.19 715.05%
2022-09-17 8 $28 $22 $25.142 $3.19 688.15%
2022-10-10 8 $28 $22 $25.5 $3.19 699.37%
2022-10-14 9 $28 $20 $24.625 $3.19 671.94%
2022-11-15 9 $28 $15 $23.555 $3.19 638.4%
2022-12-27 10 $28 $15 $23.1 $3.19 624.14%
2023-01-05 11 $28 $15 $22.636 $3.19 609.59%
2023-01-08 11 $28 $14 $20.454 $3.19 541.19%
2023-01-12 11 $28 $14 $20 $3.19 526.96%
2023-02-09 10 $28 $14 $19.8 $3.19 520.69%
2023-03-22 10 $28 $14 $19.3 $3.19 505.02%
2023-05-12 10 $28 $12 $19.1 $3.19 498.75%
2023-06-06 9 $28 $12 $18.666 $3.19 485.14%
2023-08-10 9 $28 $10 $17.555 $3.19 450.31%
2023-08-11 10 $28 $10 $17.333 $3.19 443.35%
2023-08-28 10 $28 $5 $14.777 $3.19 363.23%
2023-09-28 10 $22 $5 $14.111 $3.19 342.35%
2023-11-13 9 $22 $10 $15.125 $3.19 374.14%

The Trend in the Analyst Price Target


IPSC's average price target has moved down $4.43 over the prior 30 weeks.

IPSC reports an average of 629.34% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-12 11 28 14 19.800 4.80 312.5%
2023-01-12 11 28 14 20.000 4.80 316.67%
2023-05-12 10 28 12 18.666 3.28 469.09%
2023-08-11 10 28 10 17.333 2.80 519.04%
2023-08-28 10 28 5 14.777 2.51 488.73%

IPSC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.22 8 0 1 0 0 9

The Trend in the Broker Recommendations


Over the past 52 weeks, IPSC's average broker recommendation rating worsened by 0.03.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • IPSC has a greater upside potential (average analyst target price relative to current price) than 3318.66% of all US stocks.
  • IPSC has a higher number of analysts covering the stock than 2914.8% of stocks in the small market cap category.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, CENTURY THERAPEUTICS INC's variance in analysts' estimates is lower than -1352.61% of them.
  • In terms of how CENTURY THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 2062.58% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CENTURY THERAPEUTICS INC are AMAM, ICVX, and OMGA.

Make investment decisions regarding IPSC using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!